Meeting
2018 Gastrointestinal Cancers Symposium
Intraperitoneal chemotherapy for gastric cancer with peritoneal dissemination: A single center retrospective analysis of 82 cases.
Authors
Masahiro Yoshida
Tonan Hospital, Sapporo, Japan
Masahiro Yoshida , Yasushi Tsuji , Syutaro Oiwa , Toshizo Takayama , Naoka Okamura , Junko Sugiyama , Tetsuya Sumiyoshi , Michiaki Hirayama , Hitoshi Kondo , Syunichi Okushiba
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 170)
DOI
10.1200/JCO.2018.36.4_suppl.170
Abstract #
170
Poster Bd #
L8
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial.
First Author: Yoshiyuki Fujiwara
Poster
2020 ASCO Virtual Scientific Program
Phase II study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for gastric cancer with peritoneal metastasis: SP + IP PTX trial.
First Author: Daisuke Kobayashi
Poster
2018 ASCO Annual Meeting
An investigator initiated multicenter phase I/II study of paclitaxel, ramucirumab with nivolumab as the second-line treatment in patients with metastatic gastric cancer.
First Author: Tomohiro Nishina
Poster
2017 ASCO Annual Meeting
Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP+IP DOC trial.
First Author: Ryoji Fukushima